Nuclear translocation of alpha-synuclein increases susceptibility of MES23.5 cells to oxidative stress.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Brain Research

• Publication date

  2013-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.brainres.2013.01.024PMID 23337620
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model.

  2012cited by this paper
• Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons

  2012cited by this paper
• Disruption of protein quality control in Parkinson's disease.

  2012cited by this paper
• Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease.

  2012cited by this paper
• Conventional calpains and programmed cell death.

  2011cited by this paper
• Protein oxidative modifications in the ageing brain: Consequence for the onset of neurodegenerative disease

  2011cited by this paper
• The Histone Chaperone FACT: Structural Insights and Mechanisms for Nucleosome Reorganization*

  2011cited by this paper
• Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathology.

  2010cited by this paper
• Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis.

  2010cited by this paper
• Increased Expression of a-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis

  2010cited by this paper
• Conditional transgenic mice expressing C-terminally truncated human α-synuclein (αSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons

  2009cited by this paper
• Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization.

  2009cited by this paper
• Physiological and Pathological Role of Alpha-synuclein in Parkinson’s Disease Through Iron Mediated Oxidative Stress; The Role of a Putative Iron-responsive Element

  2009cited by this paper
• Calpain as a potential therapeutic target in Parkinson's disease.

  2008cited by this paper
• Calpain in the CNS: From Synaptic Function to Neurotoxicity

  2008cited by this paper
• Calpain-Cleavage of α-Synuclein : Connecting Proteolytic Processing to Disease-Linked Aggregation

  2007cited by this paper
• Extensive nuclear localization of α-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody

  2007cited by this paper
• Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.

  2007cited by this paper
• Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells.

  2006influential reference
• Cleavage of α-Synuclein by Calpain: Potential Role in Degradation of Fibrillized and Nitrated Species of α-Synuclein†

  2005cited by this paper
• Subcellular localisation of recombinant α- and γ-synuclein

  2005cited by this paper
• Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.

  2005cited by this paper
• Subcellular localisation of recombinant alpha- and gamma-synuclein.

  2005cited by this paper
• Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.

  2004cited by this paper
• The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

  2004cited by this paper
• Nuclear localization of alpha-synuclein and its interaction with histones.

  2003cited by this paper
• Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro.

  2003cited by this paper
• Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpain.

  2003cited by this paper
• Distinct cleavage patterns of normal and pathologic forms of α‐synuclein by calpain I in vitro

  2003cited by this paper
• Parkin Cleaves Intracellular α-Synuclein Inclusions via the Activation of Calpain*

  2003cited by this paper
• Nuclear Localization of α-Synuclein and Its Interaction with Histones†

  2003cited by this paper
• α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress

  2000cited by this paper
• α‐Synuclein Up‐Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP

  2000cited by this paper
• alpha-synuclein promotes mitochondrial deficit and oxidative stress.

  2000cited by this paper
• Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies.

  1998influential reference
• Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson’s Disease Mutation*

  1998cited by this paper
• Low frequency of α‐synuclein mutations in familial Parkinson's disease

  1998cited by this paper
• Structure and physiological function of calpains.

  1997cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?

  1996cited by this paper
• A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin

  1992cited by this paper
• Influence of isolation media on synaptosomal properties: Intracellular pH, pCa, and Ca2+ uptake

  1990cited by this paper
• Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

  1988cited by this paper

• The nuclear envelope and nuclear pore complexes in neurodegenerative diseases

  2025cites this paper
• Roflumilast-loaded nanostructured lipid carriers attenuate oxidative stress and neuroinflammation in Parkinson’s disease model

  2024cites this paper
• Special Issue “Neurobiology of Protein Synuclein”

  2024cites this paper
• Nuclear alpha-synuclein accelerates cell senescence and neurodegeneration

  2024cites this paper
• Nuclear pore and nucleocytoplasmic transport impairment in oxidative stress-induced neurodegeneration: relevance to molecular mechanisms in Pathogenesis of Parkinson’s and other related neurodegenerative diseases

  2024cites this paper
• Differential interactome mapping of aggregation prone/prion-like proteins under stress: novel links to stress granule biology

  2023cites this paper
• Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies

  2022cites this paper
• α-Synucleinopathy Exerts Sex-Dimorphic Effects on the Multipurpose DNA Repair/Redox Protein APE1 in Mice and Humans.

  2022cites this paper
• Suppressing Cdk5 Activity by Luteolin Inhibits MPP+-Induced Apoptotic of Neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β Pathways

  2021cites this paper
• DNA damage and repair in Parkinson's disease: Recent advances and new opportunities

  2020cites this paper
• Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.

  2020cites this paper
• The Roles of Hydrogen Peroxide Exposure in the Toxic Aggregation of Alpha-synuclein and Translocation of DNA Methyltransferase-1 in Human Neuroblastoma Cell Model of Parkinson's Disease

  2020cites this paper
• Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells

  2020cites this paper
• Oxidative Stress and Neurodegeneration

  2019cites this paper
• Neurochemical Aspects of Lewy Body Dementia

  2019cites this paper
• Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders

  2019cites this paper
• Nuclear localization and phosphorylation modulate pathological effects of alpha‐synuclein

  2018cites this paper
• Inhibition of phosphodiesterase 4 by FCPR16 protects SH-SY5Y cells against MPP+-induced decline of mitochondrial membrane potential and oxidative stress

  2018cites this paper
• Exploring the role of post‐translational modifications in regulating α‐synuclein interactions by studying the effects of phosphorylation on nanobody binding

  2018cites this paper
• Lipophilic antioxidants in neurodegenerative diseases.

  2018cites this paper
• FTY720 (Fingolimod) reverses &agr;‐synuclein‐induced downregulation of brain‐derived neurotrophic factor mRNA in OLN‐93 oligodendroglial cells

  2017cites this paper
• Reduced TH expression and α-synuclein accumulation contribute towards nigrostriatal dysfunction in experimental hepatic encephalopathy

  2017cites this paper
• Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management.

  2017cites this paper
• Therapeutic Importance of Curcumin in Neurological Disorders Other Than Alzheimer Disease

  2016cites this paper
• Therapeutic Potentials of Curcumin for Alzheimer Disease

  2016cites this paper
• Glutamate and Mitochondria: Two Prominent Players in the Oxidative Stress-Induced Neurodegeneration.

  2016cites this paper
• Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson’s disease

  2015cites this paper
• Oxidative stress and Parkinson’s disease

  2015cites this paper
• neuroblastoma cells with the state space model

  2015cites this paper
• Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease

  2015cites this paper
• From the baker to the bedside: yeast models of Parkinson's disease

  2015cites this paper
• Intracellular Dynamics of Synucleins: "Here, There and Everywhere".

  2015cites this paper
• Genome-wide transcriptional comparison of MPP + treated human neuroblastoma cells with the state space model

  2015cites this paper
• Parkinson Disease Mutant E46K Enhances α-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, and in Vivo*

  2015cites this paper
• The nuclear accumulation of alpha-synuclein is mediated by importin alpha and promotes neurotoxicity by accelerating the cell cycle.

  2014cites this paper
• Free Radicals, Antioxidants and Disease

  2014cites this paper
• Alpha-Synuclein Function and Dysfunction on Cellular Membranes

  2014cites this paper
• ATP13A2 and Alpha-synuclein: a Metal Taste in Autophagy

  2014cites this paper
• α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism

  2014cites this paper
• The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.

  2014cites this paper
• Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration

  2013cites this paper
• Oxidative Stress and Neurodegenerative Disorders

  2007cites this paper